You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ELU-FRa-1

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participants Receiving Flixabi or Imraldi: a French Cohort Study

Completed
  • Arthritis, Rheumatoid
  • +4 more
  • Caluire et Cuire, Auvergne-Rhône-Alpes, France
  • +59 more
Oct 17, 2022

Solid Tumors Trial in Japan (Farletuzumab Ecteribulin)

Active, not recruiting
  • Solid Tumors
  • Farletuzumab Ecteribulin
  • Matsuyama City, Ehime, Japan
  • +9 more
Jul 21, 2022

Undernutrition Trial in Dhaka (Central kitchen-prepared version of MDCF-2, MDCF-2 shelf-stable foil pouch prototype with green

Recruiting
  • Undernutrition
  • Central kitchen-prepared version of MDCF-2
  • +4 more
  • Dhaka, Bangladesh
    Mirpur
Jan 24, 2022

Adenocarcinoma of the Lung Trial in Worldwide (biological, other, drug)

Completed
Has Results
  • Adenocarcinoma of the Lung
  • Farletuzumab
  • +5 more
  • Chandler, Arizona
  • +92 more
Aug 10, 2020

Respiratory Syncytial Virus Infections Trial in Belgium, United States (RSVPreF3 OA investigational vaccine (GSK3844766A))

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine (GSK3844766A)
  • Lenexa, Kansas
  • +9 more
Jun 2, 2022

Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Rheumatoid Arthritis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

COVID-19 Trial in Thái Bình (COVIVAC vaccine)

Completed
  • COVID-19
  • COVIVAC vaccine
  • Thái Bình, Thai Binh, Vietnam
    District Health Center of Vu Thu District
Jul 12, 2023

Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)

Completed
  • Ankylosing Spondylitis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 10, 2023

Environmental Enteric Dysfunction (EED), Malnutrition, Women of Reproductive Age Trial in Dhaka (dietary supplement, procedure,

Recruiting
  • Environmental Enteric Dysfunction (EED)
  • +4 more
  • Microbiota-directed complementary food (MDCF)-2
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research, Bangladesh
May 18, 2023

Profound Bilateral Hearing Loss Trial in France (Cochlear implant manual insertion, Cochlear implant robotized insertion)

Not yet recruiting
  • Profound Bilateral Hearing Loss
  • Cochlear implant manual insertion
  • Cochlear implant robotized insertion
  • Lille, Nord, France
  • +12 more
Jan 24, 2023

Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • PIPE-307 Dose A
  • +2 more
  • (no location specified)
Oct 9, 2023

Dravet Syndrome (DS) Trial in Worldwide (Soticlestat, Placebo)

Recruiting
  • Dravet Syndrome (DS)
  • Phoenix, Arizona
  • +95 more
Jan 10, 2023

Respiratory Syncytial Virus Infections Trial in Fukuoka (RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B, Placebo)

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B
  • Placebo
  • Fukuoka, Japan
    GSK Investigational Site
Dec 7, 2021

Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of

Not yet recruiting
  • Meningococcal Meningitis
  • batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
  • +3 more
  • Surabaya, Indonesia
    Husada Utama Hospital
Nov 13, 2023

Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • iNKT Cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 24, 2023

Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Atopic Dermatitis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Jianzhong Zhang
Oct 10, 2023

Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

Not yet recruiting
  • Hypertension,Essential
  • Songling Xuemaikang Capsules
  • +2 more
  • Beijing, Beijing, China
  • +4 more
Oct 17, 2023

Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)

Not yet recruiting
  • Diabetes
  • INS062 injection、INS068 injection、HR20014 injection
  • (no location specified)
May 24, 2023

COVID-19 Trial (STI-1558)

Not yet recruiting
  • COVID-19
  • (no location specified)
Sep 15, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 22, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )

Recruiting
  • Type1diabetes
  • +2 more
  • Infusion of GIP[1-42], GIP[1-30] or placebo
  • Hellerup, Copenhagen, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 13, 2023

Lennox Gastaut Syndrome (LGS) Trial in Worldwide (Soticlestat, Placebo)

Recruiting
  • Lennox Gastaut Syndrome (LGS)
  • Phoenix, Arizona
  • +109 more
Jan 10, 2023

Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

Not yet recruiting
  • Breast Cancer
  • laboratory test (RAI14 and MACC-1 )
  • (no location specified)
Oct 18, 2023